Tirzepatide 10 mg / 3.0 ml Pen (Pre-filled) – Hilma Biocare

Description

Tirzepatide Pre-filled Pen – Hilma Biocare

Tirzepatide by Hilma Biocare is now available in a convenient pre-filled injection pen — no reconstitution, no syringes, no measuring. Simply attach a sterile needle and inject once weekly subcutaneously.

Tirzepatide is a dual GIP/GLP-1 receptor agonist — the same class of molecule as Mounjaro® / Zepbound® — offering superior weight loss results compared to single GLP-1 agonists like Semaglutide. Clinical trials demonstrated an average body weight reduction of up to 21% at 72 weeks.

Key Benefits

🔥 Superior Weight Loss — up to 21% body weight reduction in clinical trials
💊 Dual Receptor Action — GLP-1 + GIP simultaneously
🍽 Appetite Suppression — reduces hunger and prolongs satiety
💉 Pre-filled Pen — no mixing, no measuring, ready to inject
📅 Once-Weekly — convenient dosing schedule
❤️ Glycemic Control — improves blood sugar in type 2 diabetes

Dosage & Titration Protocol

Week 1–4: 2.5 mg/week (starting dose)
Week 5–8: 5 mg/week
Week 9–12: 7.5 mg/week
Week 13+: 10–15 mg/week (maintenance)

One pen (10 mg / 3.0 ml) provides 4 doses of 2.5 mg or 2 doses of 5 mg depending on titration stage.

How to Use

Attach the included sterile needle. Select dose. Inject subcutaneously into abdomen, thigh, or upper arm once weekly. Rotate injection sites.

Side Effects

Nausea, diarrhea, vomiting, constipation (mostly during initial titration, resolves with time). Titrate slowly to minimize.

Storage

Store at 2–8°C. Do not freeze. Protect from direct sunlight. Keep out of reach of children.